Stock Track | Westlake Chemical Soars 10.98% Intraday on Q4 Earnings Beat and Positive 2026 Outlook

Stock Track02-24 22:39

Westlake Chemical's stock surged 10.98% during Tuesday's intraday trading session following the release of its fourth-quarter 2025 financial results, which showed a significant earnings beat despite a slight sales miss.

The chemical producer reported an adjusted loss of $0.25 per share for Q4 2025, which beat analyst consensus estimates of a $1.43 loss by 82.48 percent. This performance came despite quarterly sales of $2.533 billion missing the $2.606 billion estimate by 2.80 percent. The company's results were impacted by $393 million in charges related to the shutdown of three North American chlorovinyls plants, with total identified items amounting to $511 million for the quarter.

Excluding these one-time items, Westlake's adjusted EBITDA was $196 million with an 8 percent margin. For the full year 2025, the company reported adjusted EBITDA of $1.1 billion. Looking ahead to 2026, Westlake stated its priority is to achieve its profitability improvement plan's targeted $600 million in EBITDA, providing a positive outlook that contributed to investor optimism despite the company's caution that macroeconomic conditions are not expected to be a tailwind to its 2026 goals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167155218?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167155218","market":"nz","top_or_hot":-1,"title":"Stock Track | Westlake Chemical Soars 10.98% Intraday on Q4 Earnings Beat and Positive 2026 Outlook","media":"Stock Track","content":"<p>Westlake Chemical's stock surged 10.98% during Tuesday's intraday trading session following the release of its fourth-quarter 2025 financial results, which showed a significant earnings beat despite a slight sales miss.</p><p>The chemical producer reported an adjusted loss of $0.25 per share for Q4 2025, which beat analyst consensus estimates of a $1.43 loss by 82.48 percent. This performance came despite quarterly sales of $2.533 billion missing the $2.606 billion estimate by 2.80 percent. The company's results were impacted by $393 million in charges related to the shutdown of three North American chlorovinyls plants, with total identified items amounting to $511 million for the quarter.</p><p>Excluding these one-time items, Westlake's adjusted EBITDA was $196 million with an 8 percent margin. For the full year 2025, the company reported adjusted EBITDA of $1.1 billion. Looking ahead to 2026, Westlake stated its priority is to achieve its profitability improvement plan's targeted $600 million in EBITDA, providing a positive outlook that contributed to investor optimism despite the company's caution that macroeconomic conditions are not expected to be a tailwind to its 2026 goals.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Westlake Chemical Soars 10.98% Intraday on Q4 Earnings Beat and Positive 2026 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Westlake Chemical Soars 10.98% Intraday on Q4 Earnings Beat and Positive 2026 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-24 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Westlake Chemical's stock surged 10.98% during Tuesday's intraday trading session following the release of its fourth-quarter 2025 financial results, which showed a significant earnings beat despite a slight sales miss.</p><p>The chemical producer reported an adjusted loss of $0.25 per share for Q4 2025, which beat analyst consensus estimates of a $1.43 loss by 82.48 percent. This performance came despite quarterly sales of $2.533 billion missing the $2.606 billion estimate by 2.80 percent. The company's results were impacted by $393 million in charges related to the shutdown of three North American chlorovinyls plants, with total identified items amounting to $511 million for the quarter.</p><p>Excluding these one-time items, Westlake's adjusted EBITDA was $196 million with an 8 percent margin. For the full year 2025, the company reported adjusted EBITDA of $1.1 billion. Looking ahead to 2026, Westlake stated its priority is to achieve its profitability improvement plan's targeted $600 million in EBITDA, providing a positive outlook that contributed to investor optimism despite the company's caution that macroeconomic conditions are not expected to be a tailwind to its 2026 goals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WLK","symbol_name":"Westlake Chemical Corp","start_time":0,"source_url":"","article_id":"1167155218","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167155218","pubTimestamp":1771943950,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Westlake Chemical's stock surged 10.98% during Tuesday's intraday trading session following the release of its fourth-quarter 2025 financial results, which showed a significant earnings beat despite...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WLK":"Westlake Chemical Corp"},"translate_title":"个股追踪|西湖化工盘中飙升10.98%，因第四季度盈利超预期和积极的2026年前景","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WLK":1},"content_text":"Westlake Chemical's stock surged 10.98% during Tuesday's intraday trading session following the release of its fourth-quarter 2025 financial results, which showed a significant earnings beat despite a slight sales miss.The chemical producer reported an adjusted loss of $0.25 per share for Q4 2025, which beat analyst consensus estimates of a $1.43 loss by 82.48 percent. This performance came despite quarterly sales of $2.533 billion missing the $2.606 billion estimate by 2.80 percent. The company's results were impacted by $393 million in charges related to the shutdown of three North American chlorovinyls plants, with total identified items amounting to $511 million for the quarter.Excluding these one-time items, Westlake's adjusted EBITDA was $196 million with an 8 percent margin. For the full year 2025, the company reported adjusted EBITDA of $1.1 billion. Looking ahead to 2026, Westlake stated its priority is to achieve its profitability improvement plan's targeted $600 million in EBITDA, providing a positive outlook that contributed to investor optimism despite the company's caution that macroeconomic conditions are not expected to be a tailwind to its 2026 goals.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167155218","isCrawlerRequest":true}